物理性质
- PSA:30.04
- LogP:1.71868
- 敏感性在浓硫酸中呈绿光黄色,稀释后转黄光红色。染色时遇铜色泽微有变化,遇铁色不变。属半菁阳离子染料。
- 外观形态红色至深红色至棕色粉末至晶体
- 储存条件室温
- 产品应用阳离子艳红5GN (cas:12217-48-0)的用途:1.阳离子艳红5GN 适宜染腈纶散纤维,纤维条和腈纶绒线,为鲜艳的红色.2.也适宜于染毛腈,锦腈混纺织物,对羊毛和锦纶很少沾色.3.也可染二醋酸纤维和氯纶以及用于腈纶,二醋酸纤维和酸改性涤纶织物的直接印花.4.阳离子艳红5GN也可与阳离子金黄 X-GL 在腈纶绒毯上拼染各种色泽艳丽的大红至红色,也用于直接印花.
- 性质描述阳离子艳红5GN (cas:12217-48-0)的化学性质:暗红色均匀粉末.易溶于水呈艳红色.在高温 (120°C) 下染色色光不变,染色时遇铜离子色泽微有变化,遇铁离子色泽不变.在pH=2~6 范围内色光稳定,匀染性好,用硫酸或甲酸染浴,色光不变.耐晒牢度 6 级.配伍值 K=4.
欧盟法规
ECHA物质C&L通报REACH预注册海关参考信息
- 2901210000-乙烯
2901220000-丙烯
2902500000-苯乙烯
2902600000-乙苯 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2005080260-A1
优先权日:2003-04-22
标 题 :Preparation of prodrugs for selective drug delivery
发明人:MILLS RANDELL L; WU GUO-ZHANG
摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.
专利号:US-4448446-A
优先权日:1981-12-09
标题:Process for the purification of triphenylmethane compounds and pressure sensitive copysheet containing same
发明人:FLORES ROBERT J
权利人:SHERWIN WILLIAMS CO
摘要:Triphenylmethane dyes are obtained in a purified or more concentrated condition which eliminates the excess aromatic amines and by-products obtained during the synthesis of the triphenylmethane dyes. These purified triphenylmethane dyes show special utility when used in combination with an electron acceptor (Lewis acid) to produce carbonless copy paper or when used as reactants in the manufacture of other dyes.
专利号:US-2018312534-A1
优先权日:2015-10-16
标题:Fluorescent anticancer platinum drugs
发明人:SARKAR ARINDAM; MANDAL SWADHIN KUMAR; SENGUPTA ANIRUDDHA; BISWAS GOUTAM; DUTTA PRADIP; SHARMA RUPALI; RAJ JUSTIN PAUL; SURYAVANSHI HEMANT; KUMARI SMITA
权利人:INVICTUS ONCOLOGY PVT LTD
摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to fluorescent platinum based compounds. The disclosure further relates to synthesis of said fluorescent platinum based compounds, nanoparticles and compositions comprising said fluorescent platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by the fluorescence changes between aforesaid platinum based compounds and corresponding free ligands, nanoparticles and compositions.
专利号:US-7888116-B2
优先权日:2004-07-22
标 题 :Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases
发明人:EGAN JOSEPHINE M; DOYLE MAIRE E
权利人:US HEALTH
摘要:Disclosed are methods for identifying and isolating a precursor cell. Also, disclosed are methods of increasing insulin synthesis from a pancreatic B-cell. Further, disclosed are methods of improving pancreatic B-cell function. Still further, disclosed are methods of preventing or delaying the onset of a metabolic disease, methods of treating or preventing a metabolic disease in a subject, and to compositions for treating or preventing a metabolic disease in a subject in need of such treatment or prevention.
专利号:US-2005202459-A1
优先权日:2003-09-23
标 题 :Intercalation-mediated synthesis of polymers
专利号:US-7368560-B2
优先权日:2003-09-23
标题:Intercalation-mediated synthesis of polymers
发明人:HUD NICHOLAS V
权利人:GEORGIA TECH RES INST
摘要:Methods and compositions for synthesizing biopolymers using an intercalator are provided. Aspects provide compositions and methods for synthesizing biopolymers with non-natural backbones or non-natural biopolymer subunits using natural biopolymer templates. Other aspects provide compositions and methods for synthesizing biopolymers using a template with a non-natural backbone on non-natural biopolymer subunits.